z-logo
open-access-imgOpen Access
The Development of a Cancer-Targeting Peptide-Drug Conjugate for the Treatment of Melanoma
Author(s) -
Cassandra Dill
Publication year - 2020
Language(s) - English
Resource type - Dissertations/theses
DOI - 10.36837/chapman.000201
Subject(s) - medicine , melanoma , drug , adverse effect , drug development , targeted therapy , drug resistance , immunotherapy , cancer , oncology , drug delivery , pharmacology , cancer research , chemistry , biology , organic chemistry , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom